First Time Loading...

Cardinal Health Inc
NYSE:CAH

Watchlist Manager
Cardinal Health Inc Logo
Cardinal Health Inc
NYSE:CAH
Watchlist
Price: 98.91 USD -3.95% Market Closed
Updated: May 5, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

46.6B
+7%
Assets
Growth Rates:
1 Year
+5%
3 Years
+4%
5 Years
+15%
7 Years
+33%
10 Years
+86%
50B
+6%
Liabilities
Growth Rates:
1 Year
+7%
3 Years
+17%
5 Years
+45%
7 Years
+74%
10 Years
+172%
-3.4B
+1%
Equity
Growth Rates:
1 Year
-56%
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Cardinal Health Inc

46.6B
Assets
50B
Liabilities
46.6B
Assets
50B
Liabilities
Current Assets 37.7B
Cash & Short-Term Investments 4.6B
Receivables 11.8B
Other Current Assets 21.3B
Non-Current Assets 8.9B
PP&E 2.4B
Intangibles 5.4B
Other Non-Current Assets 1.1B
Current Liabilities 38.3B
Accounts Payable 34.3B
Accrued Liabilities 2.8B
Other Current Liabilities 1.2B
Non-Current Liabilities 11.7B
Long-Term Debt 3.5B
Other Non-Current Liabilities 8.2B

Balance Sheet
Cardinal Health Inc

Rotate your device to view
Balance Sheet
Currency: USD
Jun-2014 Jun-2015 Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 Jun-2021 Jun-2022 Jun-2023
Assets
Cash & Cash Equivalents
2 865
4 616
2 356
6 879
1 763
2 531
2 771
3 407
4 717
4 043
Cash Equivalents
2 865
4 616
2 356
6 879
1 763
2 531
2 771
3 407
4 717
4 043
Total Receivables
5 380
6 523
7 405
8 048
7 800
8 448
8 264
9 103
10 561
11 344
Accounts Receivables
5 380
6 523
7 405
8 048
7 800
8 448
8 264
9 103
10 561
11 344
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
8 266
9 211
10 615
11 301
12 308
12 822
13 198
14 594
15 636
15 940
Other Current Assets
1 428
1 402
1 580
2 117
2 682
1 946
1 707
3 944
2 021
2 506
Total Current Assets
17 939
21 752
21 956
28 345
24 553
25 747
25 940
31 048
32 935
33 833
PP&E Net
1 459
1 506
1 796
1 879
2 487
2 356
2 792
2 820
2 818
2 897
PP&E Gross
1 459
1 506
1 796
1 879
2 487
2 356
2 792
2 820
2 818
2 897
Accumulated Depreciation
2 411
2 528
2 680
2 748
2 773
2 812
2 965
3 228
3 522
3 857
Intangible Assets
992
948
2 259
1 986
3 913
3 430
2 918
2 105
1 774
1 472
Goodwill
4 878
5 070
7 167
7 221
8 316
8 378
8 357
7 989
5 855
4 609
Other Long-Term Assets
765
866
944
681
682
1 052
759
491
496
606
Other Assets
4 878
5 070
7 167
7 221
8 316
8 378
8 357
7 989
5 855
4 609
Total Assets
26 033
N/A
30 142
+16%
34 122
+13%
40 112
+18%
39 951
0%
40 963
+3%
40 766
0%
44 453
+9%
43 878
-1%
43 417
-1%
Liabilities
Accounts Payable
12 149
14 368
17 306
17 906
19 677
21 535
21 374
23 700
27 128
29 813
Accrued Liabilities
2 164
2 592
1 803
1 983
1 999
2 117
2 231
2 957
2 842
3 059
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
801
281
587
1 327
1 001
452
10
871
580
792
Other Current Liabilities
1
2
5
5
216
5
0
96
0
42
Total Current Liabilities
15 115
17 243
19 701
21 221
22 893
24 109
23 615
27 624
30 550
33 706
Long-Term Debt
3 171
5 211
4 952
9 068
8 012
7 579
6 765
5 365
4 735
3 909
Deferred Income Tax
1 340
1 429
2 770
2 858
2 975
2 945
8 253
9 296
8 911
8 278
Minority Interest
0
0
134
138
12
2
3
3
3
1
Other Liabilities
6
3
11
19
0
0
341
374
388
375
Total Liabilities
19 632
N/A
23 886
+22%
27 568
+15%
33 304
+21%
33 892
+2%
34 635
+2%
38 977
+13%
42 662
+9%
44 587
+5%
46 269
+4%
Equity
Common Stock
2 980
3 003
3 010
2 697
2 730
2 763
2 789
2 806
2 813
2 747
Retained Earnings
4 774
5 521
6 419
4 967
4 645
5 434
1 170
1 205
280
534
Treasury Stock
1 423
2 245
2 759
731
1 224
1 790
2 066
2 186
3 128
4 914
Other Equity
70
23
116
125
92
79
104
34
114
151
Total Equity
6 401
N/A
6 256
-2%
6 554
+5%
6 808
+4%
6 059
-11%
6 328
+4%
1 789
-72%
1 791
+0%
709
N/A
2 852
-302%
Total Liabilities & Equity
26 033
N/A
30 142
+16%
34 122
+13%
40 112
+18%
39 951
0%
40 963
+3%
40 766
0%
44 453
+9%
43 878
-1%
43 417
-1%
Shares Outstanding
Common Shares Outstanding
337
328
322
316
309
299
293
291
273
251

See Also

Summary
CAH intrinsic value, competitors valuation, and company profile.
DCF Valuation
CAH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CAH stock valuation using valuation multiples.
Wall Street Estimates
CAH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CAH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.